Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Example Input: Paragraph: Samoa declared a national emergency last month and mandated that all 200,000 people living on the South Pacific island nation get vaccinated. The government has closed all schools and banned children from public gatherings. In all, 53 people have died in the outbreak since late October, including one adult and two older teenagers. Most of those who have died have been babies and young infants, including 23 children aged less than 1 and 25 children aged between 1 and 4. The government said more than 1,100 people have been admitted to hospitals since the outbreak began and about 180 people remain hospitalized. Among those hospitalized are 19 children who are in critical condition. Samoan authorities believe the virus was first spread by a traveler from New Zealand. New Zealand Prime Minister Jacinda Ardern said Monday that her country was doing everything it could to help curb the epidemic, including sending more than 50 medical professionals and thousands of vaccines to Samoa. Other countries including Britain have also sent teams and supplies. Ardern said the natural curve of infection rates meant that "sometimes things can be worse before they are better." Figures from the World Health Organization and UNICEF indicate that fewer than 30% of Samoan infants were immunized last year. That low rate was exacerbated by a medical mishap that killed two babies who were administered a vaccine that had been incorrectly mixed, causing wider delays and distrust in the vaccination program. The government said about 33,000 people were vaccinated before last month and since then, another 58,000 people have been vaccinated. The World Health Organization has set a target of wiping out measles from most of the world by next year. It says the disease is entirely preventable thanks to a safe vaccine that has been in use since the 1960s, and that measles deaths worldwide decreased by 84% between 2000 and 2016 to about 90,000 annually thanks to better immunization. Claim: 50 children killed by measles in Samoa as outbreak worsens.
Example Output: Samoa's government said Monday that another five children had died within the past day from a measles outbreak, bringing the death toll from the epidemic to more than 50 as authorities race to vaccinate the entire population.

Example Input: Paragraph: Such a test could initially be used to select patients for clinical trials of experimental treatments being developed to try to halt progression of Alzheimer's, the researchers said, and may one day move into routine use in doctors' clinics. "Alzheimer's begins to affect the brain many years before patients are diagnosed (and) many of our drug trials fail because by the time patients are given the drugs the brain has already been too severely affected," said Simon Lovestone of Oxford University, who led this work from King's College London. "A simple blood test could help us identify patients at a much earlier stage to take part in new trials and hopefully develop treatments," he said. Alzheimer's is the most common form of dementia, a brain-wasting disease which in 2010 was estimated to be costing the world $604 billion a year. The fatal disease affects 44 million people worldwide, with the number set to triple by 2050, the campaign group Alzheimer's Disease International says. Several big pharma firms including Roche, Eli Lilly, Merck & Co and Johnson & Johnson, are pursuing various approaches to get to the root cause of Alzheimer's and try to find treatments to halt its progression. Yet over the past 15 years, more than 100 experimental Alzheimer's drugs have failed in trial. Lovestone and other experts believe this may be because drug trials are conducted too late, in patients whose condition has already gone too far. A predictive test for use before people develop symptoms would help researchers select the right people for drug trials, and help show whether the experimental drugs are working. Previous studies have found that PET brain scans and tests of lumbar fluid can be used to predict the onset of dementia from people with a less severe condition known as mild cognitive impairment (MCI), but these tests are expensive and invasive, so scientists are keen to develop a cheaper, simpler blood test. MCI includes problems with day-to-day memory, language and attention. It can be an early sign of dementia, or a symptom of stress or anxiety. Around 10 percent of people diagnosed with MCI develop dementia within a year. Apart from regular assessments to measure memory decline, there is currently no accurate way of predicting who will or won't develop dementia. For this study, published in the journal Alzheimer's & Dementia, Lovestone's team used blood samples from 1,148 people - 476 with Alzheimer's, 220 with mild cognitive impairment and 452 elderly controls without dementia. They were analyzed for 26 proteins previously found to be linked with Alzheimer's. The team found 16 of these 26 proteins to be strongly associated with brain shrinkage in either MCI or Alzheimer's and then ran a second series of tests to see which of these could predict which patients would progress from MCI to Alzheimer's. With this second series, they found a combination of 10 proteins capable of predicting with 87 percent accuracy whether people with MCI would develop Alzheimer's disease within a year. Experts in the field welcomed the results but said they should be replicated in larger studies before an Alzheimer's blood test could be rolled out for use in doctors' clinics. "The results reported today are interesting, but as the authors point out there is still a very large amount of work remaining until a usable blood test for Alzheimer's disease becomes available," said Adrian Pini of the MRC Center for Developmental Neurobiology at King's College London. James Pickett, head of research at the Alzheimer's Society, said the research "does not mean that a blood test for dementia is just around the corner". "These 10 proteins can predict conversion to dementia with less than 90 percent accuracy, meaning one in 10 people would get an incorrect result," he said. "Accuracy would need to be improved before it could be a useful diagnostic test." Claim: Study paves the way for a blood test to predict Alzheimer's.
Example Output: British scientists have identified a set of 10 proteins in the blood that can predict the onset of Alzheimer's and call this an important step towards developing a test for the incurable brain-wasting disease.

Example Input: Paragraph: The story includes one expert's estimate of the cost of treating brain and spinal cord defects, but it does not discuss those costs may be affected by folic acid fortification or how the cost of fortification affects food prices. Though individuals don't face a huge cost, the aggregate cost of fortification is substantial. The story could have mentioned this at least briefly. The story highlights the decline in birth defects that is attributed to folic acid supplementation. However, it does not include a source for the statement that "fortification with the vitamin prevents an estimated 2,000 to 3,000 brain and spinal cord defects in both countries." By contrast, a CDC web page on folic acid supplementation states that each year in the U.S. "[a]n estimated 1,000 more babies are born healthy since fortification." http://www.cdc.gov/ncbddd/folicacid/data.html The story performs a service by bringing attention to the complex and difficult balancing of benefits and harms that comes with decisions about adding supplements to food. As mentioned above, the overall thrust of the story adequately captures the basic point that researchers are struggling to determine whether, what, and for whom folic acid supplementation may present potential harm. However, in some cases the comments of Dr. Mason portray a much stronger association between folic acid supplementation and cancer risk than even his own journal publications put forward. By intertwining the researcher's personal statements with references to published trials and reviews, the story blurs the distinction between speculation and evidence. The story makes clear the complexity of and uncertainty surrounding possible associations between folic acid supplementation and cancer. However, the story exaggerates what is known about potential cancer risk by highlighting comments supporting a potential link with folic acid supplementation, while failing to provide context or contrary information. The story includes an estimate by Dr. Joel Mason that "excess folic acid consumption may cause an extra 15,000 cases of colorectal cancer each year in the U.S. and Canada." But the story fails to define excess consumption, nor does it note that the are more than 160,000 new cases of colorectal cancer reported in the U.S. and Canada each year. And while the researcher may have told the reporter that he believes supplementation may be boosting cancer rates, a journal article Mason recently co-authored states that "Future studies need to explore whether a causal relationship exists between supraphysiological levels of folate intake and colorectal carcinogenesis." Also, while the story states that "researchers noticed that rates of colorectal cancer went up in North America around the same time that fortification began," the reporter should have explained the apparent discrepancy with CDC statements that between 1998 (when mandatory folic acid supplementation began in the U.S.) and 2005 both colorectal cancer incidence and deaths declined. References: Mason article: http://www.ncbi.nlm.nih.gov/pubmed/19057184 Cancer stats: http://www.cdc.gov/cancer/colorectal/statistics/ http://www.cdc.gov/cancer/colorectal/statistics/trends.htm http://www.cancer.ca/Canada-wide/About%20cancer/Cancer%20statistics/Canadian%20Cancer%20Statistics.aspx A story of this length on a subject that is hotly debated among nutrition researchers should include comments from more than one nutrition researcher. The story fails to note that according to a disclosure statement in one of his recent journal articles, Dr. Mason has been a paid consultant to Wyeth Consumer Healthcare, a manufacturer of multivitamins. Reference: Disclosure statement with Joel B. Mason, Aaron Dickstein, Paul F. Jacques, Paul Haggarty, Jacob Selhub, Gerard Dallal, and Irwin H. Rosenberg A Temporal Association between Folic Acid Fortification and an Increase in Colorectal Cancer Rates May Be Illuminating Important Biological Principles: A Hypothesis Cancer Epidemiol. Biomarkers Prev. 2007 16: 1325-1329. However, because the story does touch on several aspects of the debate, we will give it the benefit of the doubt on this criterion even though we wish other sources had been named or that other nutrition experts had been quoted. The story points out the foods that are fortified with folic acid. However, there is no advice about how individuals could estimate their daily intake of folic acid or alter it, if they desired. The story points out that folic acid supplementation of flour has been required in the U.S. since 1998. It would have been helpful to also discuss whether and how consumers could reduce their intake of folic acid, if desired. Questions about potential harms of folic acid supplementation are indeed a hot topic in nutrition research. However, most of the studies and other reports mentioned in this story were published more than two years ago, so the debate is not as new as the story implies. Given the different aspects of the debate reflected in the story, we think it's safe to assume this didn't rely solely or largely on a news release although we wonder why it relied so heavily on one nutrition expert's perspectives. Claim: Folic acid might be losing its sheen
Example Output:
This story does a good job alerting readers to scientific debate about the benefits and harms of fortifying food with folic acid. It is a welcome contrast to stories that either adore or vilify vitamins. The writer neatly lays out the historical points about supplementation of the grain supply in 1998, the benefits with regard to neural tube defect, and the newer concerns about colorectal and prostate cancer. This is a nuanced discussion, and the reader comes away with a pretty good feeling for the problem at hand. However, the story highlights the views of a single nutrition researcher in a way that blurs the distinction between his personal beliefs and the published evidence of potential links between folic acid fortification and certain cancers. The story also fails to address apparent discrepancies between the cancer statistics quoted by the researcher (which seem to indicate colorectal cancer rates rose around the time folic acid fortification was introduced) and those published by the CDC (which highlight a decline in colorectal incidence over the years since fortification began.)